No takes yet. Share an insight, caveat, or question.
Emerging drug innovation in China influences global patient access, highlighting shifts in the pharmaceutical landscape.
Vokinger et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: